Table of contents
Ovarian hyperstimulation syndrome
What's new
Updated 2023 SOGC guidelines for the prevention and management of ovarian hyperstimulation syndrome.
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of ovarian hyperstimulation syndrome are prepared by our editorial team based on guidelines from the Society of Obstetricians and Gynaecologists of Canada (SOGC 2023), the American Society for Reproductive Medicine (ASRM 2016), and the Royal College of Obstetricians and Gynaecologists (RCOG 2016).
1
2
3
4
Classification and risk stratification
Prediction of OHSS: as per ASRM 2016 guidelines, recognize that PCOS, elevated anti-Müllerian hormone values (> 3.4 ng/mL), peak estradiol levels (> 3,500 pg/mL), multifollicular development (antral follicle count > 24, development of ≥ 25 follicles), and a high number of oocytes retrieved (≥ 24) increase the risk of OHSS.
B
More topics in this section
Classification
Diagnostic investigations
Medical management
Setting of care: as per SOGC 2023 guidelines, manage patients with mild or moderate OHSS in an outpatient setting. Ensure that the patient is capable of adhering to clinical instructions and there is a system in place to assess her status every 1-2 days when offering outpatient management for more severe OHSS.
B
Show 2 more
More topics in this section
Fluid resuscitation
Diuretics
Thromboprophylaxis
Pain management
Antiemetics
GnRH antagonists
Dopamine agonists
Plasma expanders
Therapeutic procedures
Paracentesis: as per SOGC 2023 guidelines, perform paracentesis in hospitalized patients with tense ascites to alleviate the condition.
B
More topics in this section
Culdocentesis
Surgical interventions
Patient education
General counseling
As per SOGC 2023 guidelines:
Counsel each female of her personal risk for OHSS when prescribing gonadotropins.
B
Counsel females to contact a physician or a member of the team within the hospital with relevant experience, if needed, when prescribing gonadotropins in areas where patients do not have ready access to physicians familiar with the diagnosis and management of OHSS.
B
Preventative measures
Ovarian stimulation protocols: as per SOGC 2023 guidelines, use GnRH antagonist stimulation protocols in patients at high risk for OHSS. Consider administering a GnRH agonist as a substitute for hCG to trigger final oocyte maturation in order to reduce the risk of severe OHSS in patients on GnRH antagonist protocols with a very robust ovarian stimulation response.
B
Show 3 more
More topics in this section
Luteal phase support
Embryo transfer
Embryo cryopreservation
Metformin
Aspirin
Dopamine agonists
Plasma expanders
Calcium
Follow-up and surveillance
Quality improvement
Hospital regulations
As per RCOG 2016 guidelines:
Establish local protocols for the assessment and management of OHSS in all acute units where patients with suspected OHSS are likely to present and ensure access to appropriately skilled clinicians with experience in the management of this condition.
E
Ensure close liaison and coordination between centers providing fertility treatment and acute units where patients with OHSS may present.
E